March 17, 2012
UK MS News Update: Cost body backs Novartis MS pill in about-turn
- /
LONDON (Reuters) – Novartis’s multiple sclerosis pill Gilenya, one of its top new drug hopes, has been recommended for use…
MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.
March 16, 2012
Back on Track: Phase III Study of Teva’s Oral Laquinimod Published in the New England Journal of Medicine Demonstrates Clinical Benefits for Multiple Sclerosis Patients
- /
- /
March 15, 2012 Phase III ALLEGRO study results showed laquinimod reduced the annual rate of relapses, slowed the progression of…
March 16, 2012
NICE: fingolimod gets the thumbs up in the UK
- /
In its final draft guidance, out today (16 March), NICE, has recommended fingolimod, to help reduce the number of relapses for…
March 16, 2012
Myelin Repair Foundation appointed Dr. Alfred Sandrock, Chief Medical Officer from Biogen Idec to our Clinical Advisory Board
- /
We are very pleased to announce that this week the Myelin Repair Foundation appointed Dr. Alfred Sandrock, Chief Medical Officer…
March 16, 2012
Though scientists haven’t figured out a way to prevent MS, there are some things you may be able to do to reduce your risk
- /
By Connie Brichford Medically reviewed by Cynthia Haines, MD More than 400,000 people in the United States have multiple sclerosis, and someone…
March 16, 2012
Diet as a Risk Factor for MS: The Evidence
- /
- /
- /
By Connie Brichford Medically reviewed by Cynthia Haines, MD Doctors and other health-care professionals recommend a healthy diet to all their patients, and…
March 16, 2012
MAKScientific, a company focused on therapeutics that modulate cannabinoid pathways, entered into an exclusive, worldwide option and collaboration agreement with Biogen Idec
- /
- /
MAKScientific, a company focused on therapeutics that modulate cannabinoid pathways, entered into an exclusive, worldwide option and collaboration agreement with Biogen…
March 15, 2012
A Nat’l MS Society webcast on : Research in Understanding & Treating Progressive Multiple Sclerosis
- /
The National MS Society and MS Learn Online invite you to view.. Working for Me: Research in Understanding &…
March 14, 2012
Multiple Sclerosis Researchers Find Cognitive Performance Declines as Outdoor Temperature Rises
- /
- /
WEST ORANGE, NJ, Mar 13, 2012 (MARKETWIRE via COMTEX) — Kessler Foundation scientists have shown for the first time that outdoor…
March 14, 2012
In Scotland MS sufferers denied new pill treatment
- /
- /
Around 8000 Scots with multiple sclerosis are being denied access to a drug that cuts the risk of disabling relapses…
